Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,116.2
-8.3 (-0.27%)

 

  • STI Straits Times Index
    3,116.2
    -8.3 (-0.27%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,566.2
    -1.4 (-0.09%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,503.9
    -17.9 (-0.07%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,991.0
    -16.8 (-0.56%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,207.2
    408.3 (1.87%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,158.2
    31.3 (0.51%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,068.2
    0.8 (0.04%)
    Index delayed 20 minutes
  • XAO XAO
    6,763.3
    5.4 (0.08%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 611.1M
  • Value: 698.1M
  • Rise: 139
  • Fall: 151
  • Unch: 542

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.215+0.005
Y Ventures0.117+0.005
Spackman0.014+0.001
Rex Intl0.079-
G Invacom^0.156+0.006
YZJ Shipbldg SGD0.970-0.005
Singapore-eDev0.050+0.003
Genting Sing0.920+0.005
AEM1.230+0.040
Ley Choon0.017+0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,048.6 -8.4
HSI 26,503.9 -17.9
HSCEI 10,500.2 -7.7
Jakarta 6,158.2 +31.3
Nikkei 225 22,207.2 +408.3
SSE Comp 2,991.0 -16.8
Shanghai A 3,133.5 -17.6
Shanghai B 269.9 -1.2
PSE Comp 0.0
KOSPI 2,068.2 +0.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AIM IMMUNOTECH INC AIM IMMUNOTECH
Updated on 14 Oct 2019 (End of trading day)
Last (USD): 0.580 Change: -0.005 High: 0.600 Remarks: -
Change (%): -0.85 Low: 0.570
Open 0.590 Yesterday's Close 0.585
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 213,325 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.81858 Trailing EPS (USD) e -0.84102 NAV (USD) b 0.4444
PE a - Trailing PE f - Price / NAV b 1.3051
Dividend (USD) d - Cash In Hand (USD) g 0.0800 Issued & Paid-up Shares c 11,987,800
Dividend Yield (%) d - Price / Cash In Hand g 7.250 Treasury Shares h -
Beta - 75 Daysi 0.317 R-Squared - 75 Days(%)i 0.06 Market Cap (M) 6.953
Beta - 500 Daysi 0.361 R-Squared - 500 Days (%)i 0.05 Enterprise Value (M) 10.197
Piotroski F Score 2 Exchange Code AIM Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 98.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 01 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 03 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AIM IMMUNOTECH INC NYSE American 6.953 - - 1.3051 -
Industry Biotechnology NYSE American 70.161 - - 2.4657 -
Local Peer 22ND CENTURY GROUP INC NYSE American 204.492 - - 3.2817 -
Local Peer PFENEX INC NYSE American 210.820 - - 4.0690 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 139.168 - 4.482 1.0433 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 125.007 3.495 3.494 1.2433 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 115.167 - - 50.7143 -
Local Peer NANOVIRICIDES INC NYSE American 95.869 - - 9.0476 -
Local Peer CEL-SCI CORP NYSE American 73.661 - - 64.2508 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 62.688 - - 2.0352 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 50.222 - - 9.8640 -
Local Peer IBIO INC NYSE American 40.144 - - 16.3208 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 40.434 - - 1.7867 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 26.200 - - 0.8082 -
Other Local Peers ORAGENICS INC (NYSE American), ISORAY INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American)
Global Peer AMGEN INC NASDAQ 121,673.336 14.495 15.289 11.2723 2.732
Global Peer GILEAD SCIENCES INC NASDAQ 81,698.689 14.977 13.719 3.6124 3.578
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CSL ASX 110,623.593 41.232 41.233 14.7831 1.089
Global Peer CELGENE CORP NASDAQ 71,150.509 17.585 13.498 7.0789 -
Global Peer ILLUMINA INC NASDAQ 45,615.570 55.225 48.631 10.5299 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 44,618.706 21.284 20.144 8.8006 -
Global Peer BIOGEN INC NASDAQ 41,640.755 9.398 7.866 3.2148 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 33,566.130 13.732 16.221 3.4406 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,265.804 73.626 21.703 4.9012 0.815
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MODERNA INC (NASDAQ), 3SBIO (HKEx), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), NATERA INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), 10X GENOMICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), MOMENTA PHARMACEUTICALS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), POLYNOVO LIMITED (ASX), RADIUS HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), INTREXON CORP (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), VIVA BIOTECH (HKEx), EPIZYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), AVITA MEDICAL LTD (ASX), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), MESOBLAST LTD (ASX), CYTOKINETICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ARVINAS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), TRANSLATE BIO INC (NASDAQ), RETROPHIN INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AVROBIO INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), STEMLINE THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ASCLETIS-B (HKEx), CKLIFE SCIENCES (HKEx), SYNTHORX INC (NASDAQ), ESSEX BIO-TECH (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), MORPHIC HOLDING INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MERUS B V (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), SYROS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AGENUS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), XBIOTECH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), PERSONALIS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), KADMON HLDGS INC (NYSE), DYNAVAX TECHNOLOGIES CORP (NASDAQ), NEXT SCIENCE LTD (ASX), CYTOMX THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), DERMIRA INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ARDELYX INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), GERON CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), COMPUGEN (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), TELIX PHARMACEUTIC (ASX), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), DPHARMA (Bursa), SORRENTO THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), KAMADA (NASDAQ), CHIASMA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), BBI LIFE SCI (HKEx), DYADIC INTERNATIONAL INC (NASDAQ), ENZO BIOCHEM INC (NYSE), NEUROINSIGHTS NEUROTECH (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), PIERIS PHARMACEUTICALS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), XOMA CORP (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), NANTKWEST INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), CHIMERIX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), PHYLOGICA LIMITED (ASX), TREVENA INC (NASDAQ), VACCINEX INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ARAVIVE INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), CURIS INC (NASDAQ), OTONOMY INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), SELECTA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), PORT (SET), EQUILLIUM INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), CT ENTERPRISE (HKEx), IMUGENE LIMITED (ASX), CIDARA THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), ORTHOCELL LIMITED (ASX), VASCULAR BIOGENICS LTD (NASDAQ), BIONOMICS LTD (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), IVERIC BIO INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MEMPHASYS LTD (ASX), OUTLOOK THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), SAVARA INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), RHINOMED LIMITED (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), BIOTRON (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ZAFGEN INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), SENESTECH INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), EXTRAWELL PHAR (HKEx), CONTRAFECT CORP (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), BIOCEPT INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ADALTA LTD (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), PATRYS LIMITED (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), PRECIPIO INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), HEAT BIOLOGICS INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), Suntar Eco-City^ (SGX), REGENEUS LTD (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TOCAGEN INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), VAXART INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CELLMID LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ATYR PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), MEDIBIO LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), BIOXYNE LIMITED (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), MGRC (Bursa), LIVING CELL TECHNOLOGIES (ASX), ARCA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), QT Vascular (SGX), CYCLACEL PHARMA IN (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), TROVAGENE INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), BIONANO GENOMICS INC (NASDAQ), HAO WEN HLDGS (HKEx), MEGASUN (Bursa), OPGEN INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CCP TECHNOLOGIES LTD (ASX), BPH ENERGY LIMITED (ASX), NANOLLOSE LTD (ASX), SPHERIX INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), NEURALSTEM INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.007
+1.22 %
10 Days --0.130
-18.31 %
20 Days --1.190
-67.23 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.522 - 3.600 Change From 1 Year Low +0.058 % Change From 1 Year Low (%) +11.11
Change From 1 Year High -3.020 % Change From 1 Year High (%) -83.89
2 Years Range 0.522 - 3.600 Change From 2 Years Low +0.058 % Change From 2 Years Low (%) +11.11
Change From 2 Years High -3.020 % Change From 2 Years High (%) -83.89
5 Years Range 0.522 - 3.600 Change From 5 Years Low +0.058 % Change From 5 Years Low (%) +11.11
Change From 5 Years High -3.020 % Change From 5 Years High (%) -83.89
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Oct 2019 0.590 0.600 0.570 0.580 213,325 -
11 Oct 2019 0.610 0.627 0.575 0.585 286,448 -
10 Oct 2019 0.690 0.690 0.600 0.600 625,991 -
09 Oct 2019 0.576 0.580 0.550 0.573 84,298 -
08 Oct 2019 0.660 0.660 0.573 0.573 177,275 -
07 Oct 2019 0.570 0.632 0.544 0.590 362,796 -
04 Oct 2019 0.630 0.630 0.522 0.550 231,275 -
03 Oct 2019 0.630 0.644 0.560 0.603 265,557 -
02 Oct 2019 0.710 0.710 0.620 0.625 476,500 -
01 Oct 2019 0.770 0.787 0.710 0.710 427,115 -
30 Sep 2019 0.762 0.790 0.703 0.762 475,432 -
27 Sep 2019 0.730 0.790 0.710 0.743 693,778 -
26 Sep 2019 0.835 0.835 0.672 0.705 946,582 -
25 Sep 2019 0.850 1.015 0.760 0.833 3,389,427 -
24 Sep 2019 2.300 2.470 1.400 1.470 8,703,100 -
23 Sep 2019 1.820 1.850 1.660 1.720 185,723 -
20 Sep 2019 2.200 2.210 1.820 1.850 503,611 -
19 Sep 2019 3.360 3.600 2.090 2.200 8,896,997 -
18 Sep 2019 1.770 1.800 1.620 1.655 70,649 -
17 Sep 2019 1.850 1.850 1.750 1.770 30,178 -
16 Sep 2019 1.810 1.890 1.810 1.840 53,293 -
13 Sep 2019 1.940 1.940 1.850 1.870 15,635 -
Summary
Current 2 Weeks
(01 Oct 2019 to 14 Oct 2019)
0.770 0.787 0.522 0.580 3,150,580 -
Previous 2 Weeks
(17 Sep 2019 to 30 Sep 2019)
1.850 1.850 0.522 0.762 23,895,477 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.